Trial watch: Peptide-based vaccines in anticancer therapy

Peptide-based anticancer vaccination aims at stimulating an immune response against one or multiple tumor-associated antigens (TAAs) following immunization with purified, recombinant or synthetically engineered epitopes. Despite high expectations, the peptide-based vaccines that have been explored i...

Descripción completa

Detalles Bibliográficos
Autores principales: Bezu, Lucillia, Kepp, Oliver, Cerrato, Giulia, Pol, Jonathan, Fucikova, Jitka, Spisek, Radek, Zitvogel, Laurence, Kroemer, Guido, Galluzzi, Lorenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6279318/
https://www.ncbi.nlm.nih.gov/pubmed/30524907
http://dx.doi.org/10.1080/2162402X.2018.1511506

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6279318/
https://www.ncbi.nlm.nih.gov/pubmed/30524907
http://dx.doi.org/10.1080/2162402X.2018.1511506

Ejemplares similares